Is this you? Create Your Porfile
Avatar

Matthew J. Farrer

Alnylam Pharmaceuticals

Network

Latest external collaboration on country level. Dive into details by clicking on the dots.

Explore More

Hotspot

Dive into the research topics where Matthew J. Farrer is active.

Explore More

Publication

Featured researches published by Matthew J. Farrer.

Neurology: Clinical Practice | 2017

Neurobehavioral characterization of adult-onset Alexander disease A family study

Maya L. Lichtenstein; Emily Dwosh; Anupama Roy Chowdhury; Matthew J. Farrer; Marna B. McKenzie; Ilaria Guella; Daniel M. Evans; Haakon B. Nygaard; Jason R. Shewchuk; Sherri Hayden; Jason J.S. Barton; Howard Feldman

Alexander disease is a clinically heterogeneous condition associated with glial fibrillary acidic protein ( GFAP ) gene mutations initially described in infants, but juvenile and adult forms exist. Adult-onset Alexander disease (AOAD) has an insidious onset of symptoms localized largely to brainstem, but may also include cognitive dysfunction.

Archive | 2004

Method of treating neurodegenerative disease

David Bumcrot; Matthew J. Farrer; Demetrius Maraganore; Hans-Peter Vornlocher

Archive | 2014

LRRK2-Related Parkinson Disease

Joanne Trinh; Matthew J. Farrer; Owen A Ross; Ilaria Guella

Archive | 2014

Figure 1. [Schematic representation of the 144-kb...].

Joanne Trinh; Matthew J. Farrer; Owen A Ross; Ilaria Guella

Archive | 2014

Table 2. [Number of Individuals with LRRK2-Related PD with Distinct Pathogenic Findings].

Joanne Trinh; Matthew J. Farrer; Owen A Ross; Ilaria Guella

Archive | 2014

Table 3. [Selected LRRK2 Allelic Variants].

Joanne Trinh; Matthew J. Farrer; Owen A Ross; Ilaria Guella

Archive | 2014

Table 1. [Summary of Molecular Genetic Testing Used in LRRK2-Related Parkinson Disease].

Joanne Trinh; Matthew J. Farrer; Owen A Ross; Ilaria Guella

Archive | 2011

Genetic Reports Abstracts Role of sepiapterin reductase gene at the PARK3 locus in Parkinson's disease

Manu Sharma; Demetrius Maraganore; Olaf Riess; Jan O. Aasly; Anna Rita; Christine Van Broeckhoven; Matthew J. Farrer; Carlo Ferrarese; Suzana Gispert; Nobutaka Hattori; Christine Klein; Timothy Lynch; Peter Lichtner; Anthony E. Lang; George D. Mellick; Aldo Quattrone; Chiara Riva; E. Rogaeva; Owen A Ross; Peter Silburn; Tatsushi Toda; Ryan J. Uitti; Thomas Gasser; Rejko Krüger

Archive | 2004

Procédé de traitement d'une maladie neurodégénérative

David Bumcrot; Matthew J. Farrer; Demetrius Maraganore; Hans-Peter Vornlocher

Archive | 2004

Procede de traitement de maladie neurodegenerative

David Bumcrot; Matthew J. Farrer; Demetrius Maraganore; Hans-Peter Vornlocher

Explore More

Collaboration

Dive into the Matthew J. Farrer's collaboration.

Top Co-Authors
Avatar

Demetrius Maraganore

Alnylam Pharmaceuticals

View shared research outputs
Top Co-Authors
Avatar

Ilaria Guella

University of British Columbia

View shared research outputs
Top Co-Authors
Avatar

David Bumcrot

Alnylam Pharmaceuticals

View shared research outputs
Top Co-Authors
Avatar

Hans-Peter Vornlocher

Alnylam Pharmaceuticals

View shared research outputs
Top Co-Authors
Avatar

Owen A Ross

Queen's University Belfast

View shared research outputs
Top Co-Authors
Avatar

Joanne Trinh

University of British Columbia

View shared research outputs
Top Co-Authors
Avatar

Aldo Quattrone

National Research Council

View shared research outputs
Top Co-Authors
Avatar

Christine Klein

Toronto Western Hospital

View shared research outputs
Top Co-Authors
Avatar

Daniel M. Evans

University of British Columbia

View shared research outputs
Top Co-Authors
Avatar

Emily Dwosh

University of British Columbia

View shared research outputs
Explore More
Researchain Logo
Decentralizing Knowledge